PDE5A and cystic fibrosis: Additionally, the use of PDE5 inhibitors is being investigated to treat other pathologies (Dupont et al., 2014) such as in CF, in which PDE5 inhibitors might correct abnormalities on transepithelial ion transport (Noel et al., 2012).